![Geoffrey-Von-Maltzahn-600x680.jpg](https://cdn.grove.wgbh.org/dims4/default/a18623b/2147483647/strip/true/crop/519x680+40+0/resize/275x360!/quality/90/?url=https%3A%2F%2Fk1-prod-gbh.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fmedia%2Fspeaker_images%2FGeoffrey-Von-Maltzahn-600x680.jpg)
Geoffrey von Maltzahn
Co-Founder, Chief Innovation Officer, and Director, Indigo Ag
Geoffrey is co-founder and Chief Innovation Officer for Indigo, as well as a Partner at Flagship Pioneering, where he focuses on inventing technologies and starting companies to address global challenges in nutrition, environmental sustainability, and medicine. He is also a co-founder of Seres Therapeutics (NASDAQ:MCRB), Kaleido Biosciences, Sienna Biopharmaceuticals (NASDAQ:SNNA), Axcella Health and others.
-
Going Beyond the Gut: The Future of Microbiome Therapeutics
Partner:MIT Enterprise Forum Cambridge